Hairpin DNA-Based Nanomaterials for Tumor Targeting and Synergistic Therapy
International Journal of Nanomedicine · 2024
DOI: 10.2147/ijn.s461774 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2024. Verfasst von Lingling Shan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Biotechnology, School of Biology and Food Engineering, Suzhou University, Suzhou, People's Republic of China. Hauptthemen laut MEDLINE: Doxorubicin, Telomerase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
While nanoplatform-based cancer theranostics have been researched and investigated for many years, enhancing antitumor efficacy and reducing toxic side effects is still an essential problem.
Methods
We exploited nanoparticle coordination between ferric (Fe2+) ions and telomerase-targeting hairpin DNA structures to encapsulate doxorubicin (DOX) and fabricated Fe2+-DNA@DOX nanoparticles (BDDF NPs). This work studied the NIR fluorescence imaging and pharmacokinetic studies targeting the ability and biodistribution of BDDF NPs. In vitro and vivo studies investigated the nano formula's toxicity, imaging, and synergistic therapeutic effects.
Results
The enhanced permeability and retention (EPR) effect and tumor targeting resulted in prolonged blood circulation times and high tumor accumulation. Significantly, BDDF NPs could reduce DOX-mediated cardiac toxicity by improving the antioxidation ability of cardiomyocytes based on the different telomerase activities and iron dependency in normal and tumor cells. The synergistic treatment efficacy is enhanced through Fe2+-mediated ferroptosis and the β-catenin/p53 pathway and improved the tumor inhibition rate.
Conclusion
Harpin DNA-based nanoplatforms demonstrated prolonged blood circulation, tumor drug accumulation via telomerase-targeting, and synergistic therapy to improve antitumor drug efficacy. Our work sheds new light on nanomaterials for future synergistic chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmaceutical Biotechnology, School of Biology and Food Engineering, Suzhou University, Suzhou, People's Republic of China.
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, People's Republic of China.
- Departments of Diagnostic Radiology, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and College of Design and Engineering, National University of Singapore, Singapore,…
- Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Nanomedicine Translational Research Program, NUS Center for Nanomedicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Institute of Molecular and Cell Biology, Agency for Science, Technology, and Research (A*STAR), Singapore, Singapore.
ORCID-Profile: Lingling Shan
Zitieren
APA
Shan, L., Li, Y., Ma, Y., Yang, Y., Wang, J., Peng, L., Wang, W., Zhao, F., Li, W., & Chen, X. (2024). Hairpin DNA-Based Nanomaterials for Tumor Targeting and Synergistic Therapy. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s461774
Vancouver
Shan L, Li Y, Ma Y, Yang Y, Wang J, Peng L, et al. Hairpin DNA-Based Nanomaterials for Tumor Targeting and Synergistic Therapy. International Journal of Nanomedicine. 2024. doi:10.2147/ijn.s461774
BibTeX
@article{Shan2024,
author = {Shan, Lingling and Li, Yudie and Ma, Yifan and Yang, Yang and Wang, Jing and Peng, Lei and Wang, Weiwei and Zhao, Fang and Li, Wanrong and Chen, Xiaoyuan},
title = {Hairpin DNA-Based Nanomaterials for Tumor Targeting and Synergistic Therapy},
journal = {International Journal of Nanomedicine},
year = {2024},
doi = {10.2147/ijn.s461774}
}
EUVIMED